hMZF-2, the Elusive Transcription Factor

Front Genet. 2020 Dec 18:11:581115. doi: 10.3389/fgene.2020.581115. eCollection 2020.

Alain Chebly^{1

2}, Jean-Marie Peloponese³, Evelyne Ségal-Bendirdjian⁴, Jean-Philippe Merlio^{1

5}, Roland Tomb^{2

6}, Edith Chevret¹

¹ Bordeaux University, INSERM U1053 Bordeaux Research in Translational Oncology (BaRITOn), Cutaneous Lymphoma Oncogenesis Team, Bordeaux, France.
² Medical Genetics Unit (UGM), Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
³ University of Montpellier, CNRS IRIM-UMR 9004, Research Institute in Infectiology of Montpellier, Montpellier, France.
⁴ Université de Paris, INSERM UMR-S 1124, Team: Cellular Homeostasis, Cancer and Therapies, INSERM US36/CNRS UMS 2009, BioMedTech Facilities, Paris, France.
⁵ Bordeaux University Hospital Center, Tumor Bank and Tumor Biology Laboratory, Pessac, France.
⁶ Department of Dermatology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.

No abstract available

Keywords: MZF-2; Mzf; hTERT; myeloid zinc finger; myeloid zinc finger 1; myeloid zinc finger 2; telomerase; transcription factor.